| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |